Payer comparison · HCPCS J2350 · EMMETT, ID

J2350 — Ocrelizumab 30 Mg/ml Intravenous Solution

What each payer pays VALOR HEALTH (CCN 131318) for this procedure, and where each sits versus the all-payer median at this facility. Find your plan to see whether you're above or below the market here.

$38,982 All-payer median here

$42,591 Cash / self-pay here

14 payer/plan-name variants

← This hospital National rates for J2350 →

Per-payer negotiated rate at this facility. Use the column headers to sort, the filter row to narrow results.
Payer / plan	Median negotiated	vs all-payer median	Rate rows

Blue Shield of California	$44,160	13.3%	2
BLUE CROSS COMM - ALL OTHER PLANS	$43,936	12.7%	1
MODA HEALTH - ODS MEDICAL	$42,591	9.3%	1
SelectHealth	$42,591	9.3%	1
BLUE CROSS QHP	$41,739	7.1%	1
Cigna Healthcare	$40,954	5.1%	2
PacificSource	$33,478	-14.1%	2
Humana	$32,503	-16.6%	2
UnitedHealthcare	$31,248	-19.8%	2
Aetna	$29,253	-25.0%	2
Molina Healthcare	$21,071	-45.9%	1
Regence BCBS	$21,071	-45.9%	1
BLUE CROSS MCR ADV	$21,071	-45.9%	1
PGBA TRIWEST VA CCN	$20,439	-47.6%	1

Median over current-blob negotiated rates (COALESCE of standard / median / min–max midpoint, $0.01–$5M sentinel guard). Payers are canonical-grouped where a mapping exists; unmapped regional-plan name variants may appear as separate rows.